MIR6816

RNA — tumor vs normal
Tumor vs NormalRNABox plot · TCGA cohorts

Across TCGA pan-cancer cohorts, MIR6816 RNA differs between tumor and matched normal tissue in 1 of 18 cancer types tested, making tumor–normal expression one of MIR6816’s most consistent transcriptional readouts.

The strongest signal is observed in bladder urothelial carcinoma (BLCA), where MIR6816 RNA is more highly expressed in tumor relative to normal tissue. In most cancer types MIR6816 is over-expressed in tumor.

BLCA are the cancer types where MIR6816 tumor–normal differential expression is most reproducible.

RNA tumor vs normal associations by lineage

Ranked by sampling consensus. Fold-change is the tumor-versus-normal difference in MIR6816 RNA (log2); positive values indicate higher expression in tumor. p-values are from the differential-expression test.
LineageGenderStageFold-changepSampling consensus
BLCAAllAll+0.242.0392view →
Pink = over-expressed in tumor, green = repressed in tumor. Showing the 1 strongest of 1 lineages.

MIR6816–BLCA

Tumor-vs-normal expression box plot for MIR6816 RNA in BLCA.

Open the BLCA breakdown →

Exploration